CORELOGIC, INC.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

UNAUDITED

For the Nine Months Ended

September 30,

(in thousands)

2013

2012

Cash flows from operating activities:

Net income

$

120,800

$

97,399

Less: Loss from discontinued operations, net of tax

(3,205)

(18,142)

Less: (Loss)/gain from sale of discontinued operations, net of tax

(5,052)

9,277

Net income from continuing operations

129,057

106,264

Adjustments to reconcile net income from continuing operations to net cash provided by operating activities:

Depreciation and amortization

99,333

93,434

Provision for bad debt and claim losses

9,582

16,447

Share-based compensation

20,810

16,211

Excess tax benefit related to stock options

(2,895)

(643)

Equity in earnings of affiliates, net of taxes

(23,848)

(29,381)

Loss on sale of property and equipment

—

933

Loss on early extinguishment of debt

—

326

Deferred income tax

3,875

5,538

(Gain)/loss on investments and other, net

(10,825)

3,865

Change in operating assets and liabilities, net of acquisitions:

Accounts receivable

(9,158)

(46,358)

Prepaid expenses and other current assets

(2,687)

(326)

Accounts payable and accrued expenses

(11,187)

31,725

Deferred revenue

43,610

(3,667)

Income taxes

13,853

24,683

Dividends received from investments in affiliates

30,062

46,265

Other assets and other liabilities

(24,466)

(6,527)

Net cash provided by operating activities - continuing operations

265,116

258,789

Net cash (used in)/provided by operating activities - discontinued operations

(2,408)

9,684

Total cash provided by operating activities

$

262,708

$

268,473

Cash flows from investing activities:

Purchases of capitalized data and other intangible assets

(28,795)

(24,054)

Purchases of property and equipment

(51,956)

(38,753)

Cash paid for acquisitions, net of cash acquired

(70,904)

111

Purchases of investments

(2,351)

—

Cash received from sale of subsidiary, net, including discontinued operations

800

10,000

Proceeds from sale of property and equipment

—

1,852

Proceeds from sale of investments

—

8,000

Change in restricted cash

5,728

122

Net cash used in investing activities - continuing operations

(147,478)

(42,722)

Net cash provided by/(used in) investing activities - discontinued operations

2,152

(1,512)

Total cash used in investing activities

$

(145,326)

$

(44,234)

Cash flows from financing activities:

Proceeds from long-term debt

1,075

—

Repayment of long-term debt

(4,516)

(114,365)

Proceeds from issuance of stock related to stock options and employee benefit plans

11,662

9,624

Minimum tax withholding paid on behalf of employees for restricted stock units

(6,893)

(3,015)

Shares repurchased and retired

(133,565)

(226,629)

Distribution to noncontrolling interests

—

(10)

Excess tax benefit related to stock options

2,895

643

Net cash used in financing activities - continuing operations

(129,342)

(333,752)

Net cash provided by financing activities - discontinued operations

—

3

Total cash used in financing activities

$

(129,342)

$

(333,749)

Effect of exchange rate on cash

(1,341)

—

Net increase in cash and cash equivalents

(13,301)

(109,510)

Cash and cash equivalents at beginning of period

148,858

259,266

Less: Change in cash and cash equivalents - discontinued operations

(256)

8,175

Plus: Cash swept (to)/from discontinued operations

(256)

12,971

Cash and cash equivalents at end of period

$

135,557

$

154,552

Please refer to the full Form 10-Q filing for the complete financial statements and related notes that are an integral part of the financial statements.